Drug approval decision times, international reference pricing and strategic launches of new drugs

Izabela Jelovac

Post-Print from HAL

Keywords: Drug launch timing; sequential launching; marketing authorization; international reference pricing (search for similar items in EconPapers)
Date: 2015-05-28
References: Add references at CitEc
Citations:

Published in European Workshop on Health Economics, Toulouse School of Economics, May 2015, Toulouse, France

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2017)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2015)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
Working Paper: Drug approval decision times, international reference pricing and strategic launches of new drugs (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-01178636

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().